The Nasdaq hit a new high Tuesday but Target tumbled early Wednesday. Will Nvidia earnings tonight meet lofty hopes?
(Bloomberg) -- Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics Inc. shares skyrocketing. But to reach the next level the biopharmaceutical developer likely needs a partner — or a buyer.Most Read from BloombergOne Dead After Singapore Air Flight Hit By Severe TurbulenceThese Flight Routes Suffer the World’s Worst Turbulence‘It Felt Like We Had Crashed’: Singapore Air Passenger Describes Turbulence TerrorBarclays Managers Warn Some Staff to Prepare fo
Eli Lilly is Tuesday's IBD Stock Of The Day after shares surged into a buy zone, again, on promising test results for a Crohn's treatment.